MissionIR Articles

Biotechnology company VistaGen Therapeutics is on the cusp of revolutionizing drug development with its Human Clinical Trials in a Test Tube™, a versatile stem cell technology platform that brings human biology to the frontend of…

VistaGen has developed a stem cell technology platform based on the controlled transformation of human pluripotent stem cells into mature human cells, which can then be used to create bioassay systems to provide clinically relevant…

VistaGen is a biotech small-cap applying its stem cell technology to revive once-promising drug candidates that were shelved due to heart and liver safety concerns. Pharmaceutical companies spend millions of dollars and decades of time…

The U.S. FDA in August announced its approval for clinical trials using autologous neural stem cells in the treatment of multiple sclerosis (MS), a chronic autoimmune disease affecting roughly 2.1 million people around the world.…

Biotechnology company VistaGen Therapeutics is engaged in applying human pluripotent stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening. The company’s innovations are advancing drug development by predicting toxicity and other human…

The pharmaceutical industry’s current drug development paradigm is supposed to assess whether a drug candidate is both safe and effective for use in the treatment of a given disease. It’s an approach that has been…

The magic of stem cells is that, in addition to regenerating themselves, they can also generate the specialized operational cells that make up our body. Researchers are learning that there are many types of stem…

In collaboration with Dr. Gordon Keller, one of the world’s leading stem cell researchers, biotech company VistaGen Therapeutics is developing a novel human liver cell-based bioassay system, LiverSafe3D™. VistaGen believes it can use its technology…

VistaGen is a biotech company applying human pluripotent stem cell technology for drug rescue and regenerative cell therapy. The company’s drug rescue program involves combining this stem cell technology with the latest medicinal chemistry to…

VistaGen Therapeutics is applying its innovative stem cell technologies in two separate but related fields. On the one hand, the company has developed one of the most important new approaches to the field of drug…

California based VistaGen Therapeutics, a biotech company focused on using their proprietary pluripotent stem cell technology for superior predictive toxicology and drug metabolism screening, is aggressively pursuing an innovative drug development path with unusually high…

Since its inception in 1998, the U.S. National Institutes of Health (NIH) has awarded biotech small-cap VistaGen Therapeutics with $11.3 million in R&D grants, including $2.3 million to support the company’s development of its Human…

VistaGen, developers of a unique stem-cell based bioassay platform for use in the early identification and elimination of toxicity issues during drug development, plans to use their technology to create a valuable pipeline of drug…

A great technology is one that not only fills important needs, but one that can be applied in more than one way to meet important needs. It gives the developer important flexibility in determining how…

VistaGen Therapeutics, a biotech company applying pluripotent stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, today provided an update on the status of its strategic financing agreement with Autilion AG. VistaGen…

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, recently delivered an overview of key developments involving its CardioSafe 3D™ and LiverSafe 3D™ bioassay systems in…

It is said that the ultimate goal of social work is simple: to come up with a dependable and cost effective way to rehabilitate society’s unproductive members. It’s a noble goal and strangely similar to…

Some call it the Frankenstein revolution, but the fact is that it heralds what may become one of the most important developments in 21st Century medical science. It’s the use of stem cell technology to…

VistaGen is a biotech company focused on using stem cell technology to generate new, safer variants (drug rescue variants) of once-promising small molecule drug candidates that were developed but ultimately discontinued by large pharmaceutical companies…